Advisor Group Holdings, Inc. Frequency Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.33 - $0.48 $330 - $480	-1,000 Reduced 95.24%	50 $0
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $730 - $1,275	-500 Reduced 32.26%	1,050 $2,000
Q2 2022 Aug 10, 2022	SELL	$1.03 - $2.03 $130 - $257	-127 Reduced 7.57%	1,550 $3,000
Q1 2022 May 04, 2022	SELL	$1.7 - $5.72 $22,317 - $75,092	-13,128 Reduced 88.67%	1,677 $3,000
Q3 2021 Nov 05, 2021	SELL	$6.96 - $9.25 $326,639 - $434,111	-46,931 Reduced 76.02%	14,805 $104,000
Q2 2021 Aug 02, 2021	BUY	$8.05 - $11.61 $312,533 - $450,746	38,824 Added 169.45%	61,736 $615,000
Q1 2021 May 13, 2021	SELL	$7.99 - $55.01 $191 - $1,320	-24 Reduced 0.1%	22,912 $218,000
Q4 2020 Feb 10, 2021	BUY	$18.65 - $40.0 $21,559 - $46,240	1,156 Added 5.31%	22,936 $809,000
Q3 2020 Nov 12, 2020	BUY	$17.76 - $24.96 $61,982 - $87,110	3,490 Added 19.08%	21,780 $418,000
Q2 2020 Aug 14, 2020	BUY	$14.65 - $24.9 $125,257 - $212,895	8,550 Added 87.78%	18,290 $425,000
Q1 2020 May 18, 2020	BUY	$16.36 - $27.55 $159,346 - $268,337	9,740 New	9,740 $173,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.